An international registry for women exposed to Zika virus during pregnancy: time for answers.
School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland; School of Pharmaceutical Sciences, University of Lausanne, Lausanne, Switzerland; Swiss Teratogen Information Service and Division of Clinical Pharmacology, University Hospital of Lausanne, Lausanne, Switzerland; Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA.
Alice
A
Panchaud
Materno-fetal and Obstetrics Research Unit, Department "Femme-Mère-Enfant", University Hospital, Lausanne, Switzerland; Institute of Microbiology, Faculty of Biology and Medicine, University of Lausanne and University Hospital, Lausanne, Switzerland.
Manon
M
Vouga
Unit of Emerging Infectious Diseases, Institut Louis Malardé, Tahiti, French Polynesia.
Didier
D
Musso
Materno-fetal and Obstetrics Research Unit, Department "Femme-Mère-Enfant", University Hospital, Lausanne, Switzerland; Institute of Microbiology, Faculty of Biology and Medicine, University of Lausanne and University Hospital, Lausanne, Switzerland; Materno-fetal & Obstetrics Research Unit, Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland. Electronic address: david.baud@chuv.ch.
David
D
Baud
D005260:Female; D006801:Humans; D018811:Maternal Exposure; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000821:virology*; D012042:Registries; D000071244:Zika Virus; D000071243:Zika Virus Infection / Q000821:virology*